- -

Vasodilator Stress CMR and All-Cause Mortality in Stable Ischemic Heart Disease A Large Retrospective Registry

RiuNet: Repositorio Institucional de la Universidad Politécnica de Valencia

Compartir/Enviar a

Citas

Estadísticas

  • Estadisticas de Uso

Vasodilator Stress CMR and All-Cause Mortality in Stable Ischemic Heart Disease A Large Retrospective Registry

Mostrar el registro completo del ítem

Marcos-Garces, V.; Gavara, J.; Monmeneu, JV.; Lopez-Lereu, MP.; Bosch, MJ.; Merlos, P.; Pérez, N.... (2020). Vasodilator Stress CMR and All-Cause Mortality in Stable Ischemic Heart Disease A Large Retrospective Registry. JACC: Cardiovascular Imaging. 13(8):1674-1686. https://doi.org/10.1016/j.jcmg.2020.02.027

Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10251/172303

Ficheros en el ítem

[Cerrado]
Nombre: Marcos-GarcesGava ...
Tamaño: 1.102Mb
Formato: PDF
Descripción: Versión editorial
Solicitar una copia al autor

Metadatos del ítem

Título: Vasodilator Stress CMR and All-Cause Mortality in Stable Ischemic Heart Disease A Large Retrospective Registry
Autor: Marcos-Garces, Victor Gavara, Jose Monmeneu, Jose V. Lopez-Lereu, Maria P. Bosch, María J. Merlos, Pilar Pérez, Nerea Rios-Navarro, César De Dios, Elena Bonanad, Clara Racugno, Paolo Bellver Navarro, Alejandro Ventura Perez, Bruno Aguilar Botella, Jose Ventura, Silvia Moratal, David
Entidad UPV: Universitat Politècnica de València. Departamento de Ingeniería Electrónica - Departament d'Enginyeria Electrònica
Fecha difusión:
Resumen:
[EN] OBJECTIVES: This study explored the association of ischemic burden, as measured by vasodilator stress cardiovascular magnetic resonance (CMR), with all-cause mortality and the effect of revascularization on all-cause ...[+]
Palabras clave: All-cause mortality , Cardiovascular magnetic resonance , Ischemic burden , Ischemic heart disease , Prognosis , Revascularization
Derechos de uso: Cerrado
Fuente:
JACC: Cardiovascular Imaging. (issn: 1936-878X )
DOI: 10.1016/j.jcmg.2020.02.027
Editorial:
Elsevier
Versión del editor: https://doi.org/10.1016/j.jcmg.2020.02.027
Código del Proyecto:
info:eu-repo/grantAgreement/ISCIII//PI17%2F01836/ES/Estudio multidisciplinar de la obstrucción microvascular y su reparación tras un infarto agudo demiocardio: de la arteria coronaria a la microcirculación. Foco en el factor VEGF-A165b/
info:eu-repo/grantAgreement/MINECO//CB16%2F11%2F00486/ES/ENFERMEDADES CARDIOVASCULARES/
MINECO/PIE15/00013
Agradecimientos:
Dr. Marcos-Garces and Mr. Gavara contributed equally to the study. This work was supported by the Instituto de Salud Carlos III and co-funded by Fondo Europeo de Desarrollo Regional (FEDER) (grant numbers PI17/01836, ...[+]
Tipo: Artículo

References

Bodi, V., Sanchis, J., Lopez-Lereu, M. P., Nunez, J., Mainar, L., Monmeneu, J. V., … Llacer, A. (2007). Prognostic Value of Dipyridamole Stress Cardiovascular Magnetic Resonance Imaging in Patients With Known or Suspected Coronary Artery Disease. Journal of the American College of Cardiology, 50(12), 1174-1179. doi:10.1016/j.jacc.2007.06.016

Vincenti, G., Masci, P. G., Monney, P., Rutz, T., Hugelshofer, S., Gaxherri, M., … Schwitter, J. (2017). Stress Perfusion CMR in Patients With Known and Suspected CAD. JACC: Cardiovascular Imaging, 10(5), 526-537. doi:10.1016/j.jcmg.2017.02.006

Bodi, V., Husser, O., Sanchis, J., Núñez, J., Monmeneu, J. V., López-Lereu, M. P., … Llacer, Á. (2012). Prognostic Implications of Dipyridamole Cardiac MR Imaging: A Prospective Multicenter Registry. Radiology, 262(1), 91-100. doi:10.1148/radiol.11110134 [+]
Bodi, V., Sanchis, J., Lopez-Lereu, M. P., Nunez, J., Mainar, L., Monmeneu, J. V., … Llacer, A. (2007). Prognostic Value of Dipyridamole Stress Cardiovascular Magnetic Resonance Imaging in Patients With Known or Suspected Coronary Artery Disease. Journal of the American College of Cardiology, 50(12), 1174-1179. doi:10.1016/j.jacc.2007.06.016

Vincenti, G., Masci, P. G., Monney, P., Rutz, T., Hugelshofer, S., Gaxherri, M., … Schwitter, J. (2017). Stress Perfusion CMR in Patients With Known and Suspected CAD. JACC: Cardiovascular Imaging, 10(5), 526-537. doi:10.1016/j.jcmg.2017.02.006

Bodi, V., Husser, O., Sanchis, J., Núñez, J., Monmeneu, J. V., López-Lereu, M. P., … Llacer, Á. (2012). Prognostic Implications of Dipyridamole Cardiac MR Imaging: A Prospective Multicenter Registry. Radiology, 262(1), 91-100. doi:10.1148/radiol.11110134

Katritsis, D. G., Mark, D. B., & Gersh, B. J. (2018). Revascularization in stable coronary disease: evidence and uncertainties. Nature Reviews Cardiology, 15(7), 408-419. doi:10.1038/s41569-018-0006-z

Kelle, S., Chiribiri, A., Vierecke, J., Egnell, C., Hamdan, A., Jahnke, C., … Gebker, R. (2011). Long-Term Prognostic Value of Dobutamine Stress CMR. JACC: Cardiovascular Imaging, 4(2), 161-172. doi:10.1016/j.jcmg.2010.11.012

Caliendo, M., & Kopeinig, S. (2008). SOME PRACTICAL GUIDANCE FOR THE IMPLEMENTATION OF PROPENSITY SCORE MATCHING. Journal of Economic Surveys, 22(1), 31-72. doi:10.1111/j.1467-6419.2007.00527.x

Timmis, A., Raharja, A., Archbold, R. A., & Mathur, A. (2018). Validity of inducible ischaemia as a surrogate for adverse outcomes in stable coronary artery disease. Heart, 104(21), 1733-1738. doi:10.1136/heartjnl-2018-313230

Hachamovitch, R., Hayes, S. W., Friedman, J. D., Cohen, I., & Berman, D. S. (2003). Comparison of the Short-Term Survival Benefit Associated With Revascularization Compared With Medical Therapy in Patients With No Prior Coronary Artery Disease Undergoing Stress Myocardial Perfusion Single Photon Emission Computed Tomography. Circulation, 107(23), 2900-2907. doi:10.1161/01.cir.0000072790.23090.41

Hachamovitch, R., Rozanski, A., Shaw, L. J., Stone, G. W., Thomson, L. E. J., Friedman, J. D., … Berman, D. S. (2011). Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy. European Heart Journal, 32(8), 1012-1024. doi:10.1093/eurheartj/ehq500

2013 ESC guidelines on the management of stable coronary artery disease. (2013). European Heart Journal, 34(38), 2949-3003. doi:10.1093/eurheartj/eht296

Doenst, T., Haverich, A., Serruys, P., Bonow, R. O., Kappetein, P., Falk, V., … Sigusch, H. (2019). PCI and CABG for Treating Stable Coronary Artery Disease. Journal of the American College of Cardiology, 73(8), 964-976. doi:10.1016/j.jacc.2018.11.053

A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease. (2009). New England Journal of Medicine, 360(24), 2503-2515. doi:10.1056/nejmoa0805796

Boden, W. E., O’Rourke, R. A., Teo, K. K., Hartigan, P. M., Maron, D. J., Kostuk, W. J., … Weintraub, W. S. (2007). Optimal Medical Therapy with or without PCI for Stable Coronary Disease. New England Journal of Medicine, 356(15), 1503-1516. doi:10.1056/nejmoa070829

Van Nunen, L. X., Zimmermann, F. M., Tonino, P. A. L., Barbato, E., Baumbach, A., Engstrøm, T., … Pijls, N. H. J. (2015). Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial. The Lancet, 386(10006), 1853-1860. doi:10.1016/s0140-6736(15)00057-4

De Bruyne, B., Pijls, N. H. J., Kalesan, B., Barbato, E., Tonino, P. A. L., Piroth, Z., … Fearon, W. F. (2012). Fractional Flow Reserve–Guided PCI versus Medical Therapy in Stable Coronary Disease. New England Journal of Medicine, 367(11), 991-1001. doi:10.1056/nejmoa1205361

Neumann, F.-J., Sousa-Uva, M., Ahlsson, A., Alfonso, F., Banning, A. P., Benedetto, U., … Head, S. J. (2018). 2018 ESC/EACTS Guidelines on myocardial revascularization. European Heart Journal, 40(2), 87-165. doi:10.1093/eurheartj/ehy394

Al-Lamee, R., Thompson, D., Dehbi, H.-M., Sen, S., Tang, K., Davies, J., … Malik, I. S. (2018). Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial. The Lancet, 391(10115), 31-40. doi:10.1016/s0140-6736(17)32714-9

Shaw, L. J., Hausleiter, J., Achenbach, S., Al-Mallah, M., Berman, D. S., Budoff, M. J., … Min, J. K. (2012). Coronary Computed Tomographic Angiography as a Gatekeeper to Invasive Diagnostic and Surgical Procedures. Journal of the American College of Cardiology, 60(20), 2103-2114. doi:10.1016/j.jacc.2012.05.062

Herwig, A., & Weltermann, B. (2017). Study protocol for a matter of heart: a qualitative study of patient factors driving overuse of cardiac catheterisation. BMJ Open, 7(9), e017629. doi:10.1136/bmjopen-2017-017629

Maron, D. J., Hochman, J. S., O’Brien, S. M., Reynolds, H. R., Boden, W. E., Stone, G. W., … Rosenberg, Y. (2018). International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design. American Heart Journal, 201, 124-135. doi:10.1016/j.ahj.2018.04.011

[-]

recommendations

 

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro completo del ítem